STENABOLIC (SR9009)

What Is Stenabolic SR9009?

Stenabolic (SR9009) was developed by researchers at The Scripps Research Institute to study the Rev-ErbA nuclear receptor — a key regulator of metabolism and energy expenditure.

When activated, this receptor modulates genes responsible for fat oxidation, glucose metabolism, and mitochondrial biogenesis, essentially “reprogramming” how the body uses and stores energy.

Because of its ability to enhance stamina and fat metabolism without hormonal disruption, SR9009 has become a leading research compound for metabolic efficiency, endurance, and weight-management studies.

Key Benefits Observed in Research

• Enhances Endurance: Improves exercise performance and fatigue resistance.

• Boosts Fat Metabolism: Encourages greater fat oxidation and energy conversion.

• Improves Mitochondrial Function: Increases the number and efficiency of mitochondria in muscle tissue.

• Supports Circadian Rhythm Regulation: Helps optimize biological energy cycles and sleep-wake balance.

• Reduces Cholesterol and Triglycerides: Promotes healthier lipid metabolism in animal models.

These combined effects make SR9009 one of the most comprehensive compounds for metabolic and cardiovascular research.

Mechanism of Action

Unlike SARMs, SR9009 works by activating Rev-ErbA, a nuclear receptor that regulates metabolism and circadian rhythm. This activation increases energy expenditure while reducing fat storage.

In laboratory studies, SR9009 has been shown to:

• Boost basal metabolic rate even during rest

• Enhance mitochondrial density and oxidative capacity

• Reduce inflammation and fat accumulation

• Improve glucose tolerance and insulin sensitivity

Essentially, it helps researchers understand how the body can be “reprogrammed” for better energy efficiency and endurance performance.

Suggested Dosage & Usage (For Research Purposes Only)

Pharmaqo SR9009 is supplied for laboratory and scientific research only.

Typical research dosage range:

• 10–30mg daily for 6–8 weeks (depending on study objectives).

Stacking potential:

• For endurance research: Often paired with Cardarine (GW-501516) for synergistic effects on stamina and fat metabolism.

• For recomposition studies: Combined with MK-2866 (Ostarine) or LGD-4033 (Ligandrol) to preserve lean muscle during fat metabolism research.

Important: SR9009 is not approved for human consumption and is intended exclusively for scientific and educational use.

Pros and Cons

Pros

• Promotes fat loss without hormonal interference

• Improves endurance and exercise output

• Supports healthy cholesterol and glucose metabolism

• Enhances energy efficiency and mitochondrial function

• Non-steroidal and non-suppressive compound

Cons

• Research compound only — not for medical or human use

• A short half-life may require multiple daily dosing in experiments

• Limited long-term study data available

Stenabolic’s non-hormonal and highly specific mechanism makes it a unique tool for studying energy balance and metabolic optimization.